MedPath

Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment

Not Applicable
Completed
Conditions
Caregiver
Malignant Neoplasm
Interventions
Behavioral: Music Therapy
Registration Number
NCT03683420
Lead Sponsor
Barbara Ann Karmanos Cancer Institute
Brief Summary

This trial studies how well music works in reducing distress in participants with cancer during chemotherapy treatment. Music in participants receiving cancer treatment such as infusion treatment and caregiver may reduce pain, anxiety, and distress and improve participant's psychological and physiological wellbeing.

Detailed Description

PRIMARY OBJECTIVES:

I. To test the effect of patients? listening to music on level of distress during cancer treatment.

SECONDARY OBJECTIVES:

I. To explore the influence of covariates (patients? sociodemographics, musical background, and clinical variables) on the association between patients? listening to music and level of distress during cancer treatment.

II. To explore the interdependence of adjustment among patients and their caregivers on the association between.

OUTLINE: Participants and caregivers are randomized to 1 of 2 groups.

GROUP I: Participants and caregivers listen to music of their choice for up to 60 minutes during infusion session.

GROUP II: Participants and caregivers do not listen to music during infusion session and are placed on music waitlist.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Able to speak, read, write and understand English
  • Have sufficient hearing capacity to hear music
Read More
Exclusion Criteria
  • Patients with cognitive or perceptual disturbances will be excluded
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group I (music)Music TherapyThe intervention is a behavioral intervention, which consists of giving patients and caregivers iPods to listen to music for up to 60 minutes while the patient is receiving a chemo infusion. The study consists of a presurvey, active listening period, and a post-survey.
Primary Outcome Measures
NameTimeMethod
Changes in pain assessed by Visual Analogue Scale1 hour

Clinical variables will be summarized by median and range for continuous variables and by count and percentage for categorical variables. The changes between pre- and post-survey will be compared between control and experimental groups using an unpaired t-test. Total scores are reported with the total scores ranging from 0-10; higher scores indicate more pain.

Changes in mood assessed by Positive and Negative Affect Scale1 hour

Clinical variables will be summarized by median and range for continuous variables and by count and percentage for categorical variables. The changes between pre- and post-survey will be compared between control and experimental groups using an unpaired t-test. There are two subscales: Positive Affect and Negative Affect. Scores for each subscale (10 items each) range from 10 to 50 with higher scores meaning higher levels of affect (either higher positive or higher negative affect).

Changes in distress assessed by Distress Thermometer.1 hour

Clinical variables will be summarized by median and range for continuous variables and by count and percentage for categorical variables. The changes between pre- and post-survey will be compared between control and experimental groups using an unpaired t-test. Total scores are reported with the total scores ranging from 0-10; higher scores indicate more pain.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wayne State University/Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath